News

Stocktwits on MSN23h
Fate Therapeutics Stock Draws Investor Attention After FDA Grants Special Designation To Its CAR T-Cell Therapy: Retail Stays Optimistic
Shares of Fate Therapeutics, Inc. (FATE) were in the spotlight on Monday morning after the company said that the U.S. Food ...
Fate Therapeutics gets RMAT status from FDA for Lupus treatment
Fate Therapeutics (NASDAQ:FATE) announced that the U.S. FDA granted Regenerative Medicine Advanced Therapy designation to ...
Transcend Biologics Launches Tropovettm PRP: Advancing Regenerative Care In Veterinary Medicine
Transcend Biologics launches TropoVetTM PRP, a one-step regenerative therapy that enhances healing and recovery for pets using advanced platelet tech ...
The Business Journals12d
Regenerative medicine firm Vivex Biologics navigates complex FDA approval landscape
Vivex Biologics' chairman reveals the unexpected challenges of bringing regenerative medicine products to market. Regenerative medicine holds immense promise for treating a wide range of injuries ...
Yahoo Finance11d
Royal Biologics Withdraws From the Alliance of Wound Care Stakeholders Over Support for Restrictive LCD Policies
HACKENSACK, NEW JERSEY / ACCESS Newswire / April 4, 2025 / Royal Biologics, a leader in regenerative biologic technologies and wound care solutions, today announced its formal decision to part ...
Orthobiologics Research Initiative Launches Fundraising Campaign to Advance Equity in Regenerative Medicine
The Orthobiologics Research Initiative (ORI), a nonprofit launched by a team of physician leaders at Regenerative Orthopedics & Sports Medicine, is proud to announce its ongoing fundraising efforts to ...